It is prescribed for conditions such as vaginal yeast infection, oral thrush and oesophageal candidiasis. Fluconazole blocks fungal ergosterol production, weakening the fungal cell membrane.
It is prescribed for conditions such as vaginal yeast infection, oral thrush and oesophageal candidiasis. Fluconazole blocks fungal ergosterol production, weakening the fungal cell membrane.
Diflucan is an oral antifungal containing fluconazole for Candida and other susceptible fungal infections.
Diflucan is used when the suspected or confirmed organism is susceptible to fluconazole. The treatment plan depends on the infection site, its severity, kidney function, immune status and the species of Candida involved.
Common clinical applications include:
A vaginal yeast infection usually produces itching, soreness and thick discharge. Oral thrush may cause creamy plaques, burning or altered taste. Oesophageal candidiasis can cause pain behind the breastbone or difficulty swallowing. These symptoms can overlap with bacterial, viral and inflammatory conditions, so fluconazole is not suitable for every cause of genital, oral or gastrointestinal discomfort. Testing may be needed when symptoms are recurrent or atypical.
Systemic infections such as candidemia and cryptococcal meningitis are medically serious. They are not conditions for self-treatment with a single capsule. Hospital teams may use blood cultures, imaging, lumbar puncture, susceptibility testing and repeated clinical assessment to select therapy.
The US FDA label includes indications for several Candida infections and cryptococcal disease. European and UK prescribing information also describes the need to consider species susceptibility and renal function when choosing a regimen [2].
Diflucan contains fluconazole, a triazole antifungal within the wider azole antifungal class. The product is supplied as oral capsules. Fluconazole may be used for localised mucosal infections and, at clinician-selected regimens, more serious infections affecting internal organs or the bloodstream.
Fluconazole works selectively on fungal cells. It inhibits lanosterol 14-alpha-demethylase, an enzyme linked to fungal cytochrome P450. This interrupts the production of ergosterol, a lipid that helps maintain the fungal cell membrane. The damaged membrane becomes less stable, which limits fungal growth and may lead to cell death [1].
The mechanism is different from that of antibacterial medicines. Antibiotics target bacteria, while fluconazole targets a biochemical pathway needed by fungi. Human cells do not produce ergosterol, which gives fluconazole its useful degree of fungal selectivity, although the medicine can still affect human liver enzymes and interact with other treatments.
Fluconazole dosing differs between strengths and between users, so there is no single amount that suits everyone. The appropriate regimen depends on the infection being treated and the patient's clinical factors.
A prescriber may select:
Swallow the capsule with water. It may be taken with or without food. Follow the prescribed schedule rather than taking extra capsules to accelerate symptom relief.
If a dose is missed, take it when remembered unless the next scheduled dose is close. Do not double the next dose. For a one-dose treatment, a missed dose should be discussed with the prescriber because the correct response depends on the infection and the intended schedule.
People with reduced kidney function may need a lower maintenance dose or a longer interval between doses. Liver disease, pregnancy, breastfeeding, immune suppression and interacting medicines can also change the treatment decision.
Fluconazole is a systemic triazole. Other antifungal approaches differ in spectrum, route and monitoring requirements.
| Treatment approach | Main pharmacological distinction | Typical clinical role |
|---|---|---|
| Fluconazole | Oral triazole that inhibits fungal ergosterol synthesis | Susceptible Candida and selected cryptococcal infections |
| Itraconazole | Oral triazole with a broader but more variable interaction profile | Selected mucosal, skin and systemic fungal infections |
| Amphotericin B | Polyene that binds fungal membrane sterols | Severe invasive fungal disease, often in hospital care |
| Topical antifungal | Local treatment with limited systemic exposure | Selected superficial or vaginal infections |
Itraconazole may be chosen when the suspected organism is less responsive to fluconazole or when a different antifungal spectrum is required. It has complex absorption and interaction considerations.
Amphotericin B is used for severe infections where rapid, intensive treatment is required. Its intravenous formulations require clinical monitoring because kidney toxicity, infusion reactions and electrolyte disturbances can occur.
Topical treatment may be appropriate for selected superficial infections. It can reduce systemic exposure, though it may be unsuitable for oesophageal disease, bloodstream infection or infection in an immunosuppressed host.
Terconazole is a topical azole used for some vaginal yeast infections. Its local route differs from oral fluconazole, and the choice depends on pregnancy status, recurrence, symptoms, previous response and clinician assessment.
Several patterns make treatment less successful:
Diflucan may not be suitable when the suspected or confirmed organism is not susceptible to fluconazole. Treatment selection requires consideration of the infection site, its severity, kidney function, immune status and the Candida species involved.
Dosing differs between strengths and between users, so there is no single amount that suits everyone. A prescriber may choose a renal-adjusted regimen when kidney function is reduced and may recommend a longer or more intensive course for persistent, recurrent or serious systemic fungal disease.
Fluconazole is tolerated by many patients, yet adverse effects can occur. Commonly reported reactions include:
These effects are often mild and short-lived. Taking the capsule with a meal may make nausea easier to manage, although food is not required for absorption. Dizziness can affect concentration, especially when starting treatment or when another medicine has similar effects.
Rare but serious reactions include severe skin reactions, facial or throat swelling, breathing difficulty, significant liver injury, seizures and abnormal heart rhythm. A widespread blistering rash, peeling skin, yellowing of the skin or eyes, dark urine, fainting, or swelling of the lips requires urgent medical assessment.
Fluconazole can prolong the QT interval in susceptible patients. The risk rises with certain heart medicines, electrolyte disturbances, structural heart disease and other drugs that affect cardiac repolarisation. It can also alter liver enzyme activity, changing the concentration of medicines taken at the same time.
Liver function monitoring may be used during prolonged courses, especially in people with existing liver disease or when symptoms suggest hepatic injury. A short treatment course for uncomplicated infection generally involves less monitoring than therapy for invasive candidiasis.
In clinical practice, doctors usually focus first on confirming the infection and its site. A single oral dose can be convenient for selected vaginal Candida infections, but it is not a universal treatment for genital symptoms.
For oral thrush, clinicians assess contributing factors such as inhaled corticosteroids, dentures, diabetes, antibiotic exposure and immune suppression. Recurrent episodes may require investigation rather than repeated short courses.
Prescribers also distinguish colonisation from invasive disease. Candida detected in a specimen does not always mean that systemic antifungal therapy is needed. Bloodstream infection, meningitis and infection in a severely immunosuppressed host require urgent specialist management.
A practical prescribing decision includes the likely Candida species, renal function, liver history, pregnancy status and interacting medicines. Consistent use of the prescribed regimen matters more than taking extra doses when symptoms fluctuate.
Dizziness, headache or visual disturbance can occur with fluconazole and may affect driving or machinery work. The MHRA safety framework used in 2025 supports avoiding hazardous activity when a medicine causes impaired alertness or coordination. Do not drive until you know how the capsule affects you, especially if you also use sedatives, opioids or alcohol.
Symptoms may take time to settle, and discomfort can remain after the fungal burden has fallen. NHS clinical practice in 2025 supports reassessment when symptoms persist, recur quickly or worsen after treatment. Do not keep taking additional capsules without identifying whether the infection is Candida and whether the organism is susceptible to fluconazole.
Both medicines are azole antifungals, but fluconazole and itraconazole have different absorption, interaction and tissue-distribution profiles. EMA prescribing information reviewed in 2025 describes these differences as relevant when selecting therapy for mucosal, skin or systemic fungal disease. Itraconazole may be preferred for some organisms or infection sites, while fluconazole is often selected when its predictable absorption and susceptibility profile fit the case.
Pregnancy requires an individual decision because oral fluconazole exposure varies by dose and duration. WHO clinical safety principles in 2025 support selecting the treatment with the best balance of maternal benefit and fetal safety, rather than treating recurrent symptoms without assessment. Fluconazole enters breast milk, so breastfeeding advice depends on the regimen and the infant's health.
Urgent assessment is needed for facial swelling, breathing difficulty, fainting, blistering or peeling skin, a widespread rash, yellow skin, dark urine or severe abdominal pain. MHRA adverse-reaction guidance in 2025 treats these findings as possible serious hypersensitivity, skin or liver reactions. Palpitations or collapse are also urgent because fluconazole can contribute to rhythm problems in susceptible patients.
Discuss pregnancy, breastfeeding, kidney disease, liver disease, previous azole reactions and every regular medicine. The EMA product information updated before 2025 gives specific attention to anticoagulants, antiepileptics, immunosuppressants, statins and medicines that prolong the QT interval. Mention whether the infection has happened repeatedly, whether previous treatment failed and whether symptoms include fever, pelvic pain, trouble swallowing or confusion.
A previous serious allergic reaction to fluconazole or another azole rules out further use unless a specialist gives a carefully supervised alternative plan. The FDA prescribing information states that fluconazole should not be used with certain medicines capable of causing severe rhythm disturbances. A suspected bloodstream infection or cryptococcal meningitis also rules out self-treatment because urgent specialist antifungal management is required.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Based on 5 reviews
I used the prescribed single-dose treatment for a typical yeast infection. The itching eased over the next couple of days, although I had mild nausea that evening.
Bath One day 21 Oct 2026The first course helped, but symptoms returned within a month. My GP arranged testing instead of telling me to keep repeating the capsule, which found that the problem was not simply recurring thrush.
Liverpool One month 30 Sept 2026I took fluconazole during a longer treatment plan for oral thrush. My mouth improved gradually, but I noticed a headache for the first two days and needed several doses rather than one.
Edinburgh Longer course 11 Oct 2026The capsule was easy to take and the burning improved, but the discharge continued. Further assessment showed bacterial vaginosis, so fluconazole had not been the right treatment for the whole problem.
York One dose 5 Oct 2026I had a widespread rash after a dose and stopped taking more until I received urgent advice. It was treated as a possible medicine reaction rather than something to ignore.
Middlesbrough One day 26 Oct 2026
